ClinicalTrials.Veeva

Menu

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Abbott logo

Abbott

Status

Completed

Conditions

Heart Failure
Sudden Cardiac Death
Tachyarrhythmias

Treatments

Device: SJ4 connector and RV high voltage SJ4 lead

Study type

Observational

Funder types

Industry

Identifiers

NCT00940888
60020938

Details and patient eligibility

About

The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.

Enrollment

1,701 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have an approved indication per ACC/AHA/HRS guidelines for implantation of heart failure or life-threatening ventricular tachyarrhythmias and will be implanted with a St. Jude Medical SJ4 system.
  • Have the ability to provide informed consent for study participating and be willing and able to comply with the prescribed follow-up test and schedule of evaluations.

Exclusion criteria

  • Be currently participating in a clinical investigation that includes an active treatment arm.
  • Have a life expectancy of less than 6 months due to any condition.
  • Be less than 18 years of age.

Trial design

1,701 participants in 1 patient group

No treatment: ICD/CRTD-indicated
Treatment:
Device: SJ4 connector and RV high voltage SJ4 lead

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems